Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.


PURPOSE OF REVIEW Systemic sclerosis (SSc) remains one of the last severe autoimmune disease with a poor prognosis and modest response to immunosuppressive therapy. Mortality in severe diffuse disease with internal organ involvement is elevated. Autologous hematopoietic transplantation (HSCT) has emerged in the last decade as a promising disease-modifying… (More)
DOI: 10.1097/BOR.0b013e32834aa45f

3 Figures and Tables


  • Presentations referencing similar topics